EGFR and non-small cell lung carcinoma: This meta-analysis included twenty-one studies (1639 patients) investigating the diagnostic accuracy of EGFR-T790M mutation testing by ctDNA in patients with advanced NSCLC who progressed to prior EGFR-TKI.